<?xml version="1.0" encoding="UTF-8"?>
<p>We next aimed to determine whether 
 <italic>Usp18</italic> is capable of activating immune responses upon systemic VSV infection [
 <xref rid="B30-vaccines-08-00142" ref-type="bibr">30</xref>]. In strong contrast to WT mice, 
 <italic>CD169</italic>-Cre
 <sup>+/
  <italic>ki</italic>
 </sup> x 
 <italic>Usp18</italic>
 <sup>fl/fl</sup> mice showed highly reduced IFNα serum levels following systemic VSV infection (
 <xref ref-type="fig" rid="vaccines-08-00142-f001">Figure 1</xref>D). Consistently, the relative expression of 
 <italic>Ifna2</italic>, 
 <italic>Ifna4</italic> and 
 <italic>Ifnb1</italic> was highly decreased in the spleen (
 <xref ref-type="fig" rid="vaccines-08-00142-f001">Figure 1</xref>E) and LN (
 <xref ref-type="fig" rid="vaccines-08-00142-f001">Figure 1</xref>F) 16 h post-infection in 
 <italic>CD169</italic>-Cre
 <sup>+/
  <italic>ki</italic>
 </sup> x 
 <italic>Usp18</italic>
 <sup>fl/fl</sup> mice. We concluded that enforced replication in CD169
 <sup>+</sup> MΦs depended on 
 <italic>Usp18</italic> and is necessary for a strong early immune response. Next, we addressed the involvement of 
 <italic>Usp18</italic> in CD169
 <sup>+</sup> macrophages during the activation of the adaptive immune response. The neutralizing antibody response in 
 <italic>CD169</italic>-Cre
 <sup>+/
  <italic>ki</italic>
 </sup> x 
 <italic>Usp18</italic>
 <sup>fl/fl</sup> was impaired when compared to control mice (
 <xref ref-type="fig" rid="vaccines-08-00142-f001">Figure 1</xref>G,H). To further address the influence of 
 <italic>Usp18</italic> expression in CD169
 <sup>+</sup> MΦs in overall survival, we infected mice intravenously with a dose of VSV sublethal to WT mice. 
 <italic>CD169</italic>-Cre
 <sup>+/
  <italic>ki</italic>
 </sup> x 
 <italic>Usp18</italic>
 <sup>fl/fl</sup> mice were highly susceptible to VSV infection, which lead to the early death of these mice (
 <xref ref-type="fig" rid="vaccines-08-00142-f001">Figure 1</xref>I).
</p>
